2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Retinal Neovascularization: new trials by email Literature Review of Retinal Neovascularization trials Research Report on Retinal Neovascularization
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration rAAV.sFlt-1, Control (ranibizumab alone) - Macular Degeneration, Age-related Maculopathies | Phase 1 / Phase 2 | Completed | Lions Eye Institute, Perth, Western Australia | 40 | 2011-12-01 | 2017-09-01 |
| Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD) AAV2-sFLT01 - Macular Degeneration, Age-Related Maculopathies | Phase 1 | Completed | Genzyme, a Sanofi Company | 19 | 2010-01-11 | 2018-08-22 |
Eye Diseases (2) · Macular Degeneration (2) · Retinal Degeneration (2) · Retinal Diseases (1) · Wet Macular Degeneration (1)
Eye Diseases, Hereditary (2) · Metaplasia (2) · Neovascularization, Pathologic (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Retinal Diseases (1)
Ranibizumab (1)
Genzyme, a Sanofi Company (1) · Lions Eye Institute, Perth, Western Australia (1)
Australia (1) · United States (1)